Moles and Melanoma

This refers to two types of skin growths. Nevi are usually harmless moles. Melanomas are a type of skin cancer that can develop from moles or appear on the skin. Both need to be checked by a doctor.

Condition

What people with Moles and Melanoma report

Every report comes from a Lived member, sent anonymously.

Have you tried Keytruda (Pembrolizumab) for Moles and Melanoma?

NameHow it went

About Moles and Melanoma

What It Is

A mole, or nevus (plural nevi), is a small growth that forms when pigment cells in the skin, called melanocytes, gather in a cluster. Moles are extremely common: most adults have between 10 and 40, usually small, round or oval, and evenly pink, tan or brown. New moles tend to appear through childhood and early adulthood, until about age 40, and they often fade later in life. Ordinary moles are not cancer. Melanoma is a cancer that starts in those same pigment cells. It is much less common than other skin cancers but more dangerous, because it can grow deeper into the skin and spread through the lymph system or bloodstream to organs such as the lungs, liver, bones or brain. The two are grouped together because the practical question is how to tell a harmless mole from one that needs attention. Most melanomas do not grow out of an existing mole; more often they appear as a new spot on skin that previously looked normal. Melanoma can also start in the eye or in mucous membranes such as the lining of the mouth, but those forms behave differently and are not the focus here. Between the two sits the dysplastic nevus, often called an atypical mole. It is not cancer, but it is usually larger than an ordinary mole (more than 5 millimeters across, about the width of a pencil eraser), with a mix of colors and an irregular edge that can fade into the surrounding skin. About 1 in 10 people has at least one. An atypical mole itself rarely becomes melanoma, but having several is a sign of higher overall melanoma risk.

Causes & Risk Factors

Ultraviolet (UV) light, from the sun and from tanning beds and sunlamps, is the main avoidable cause. It damages the DNA of skin cells, and both total lifetime sun exposure and severe, blistering sunburns, particularly in childhood and the teenage years, raise melanoma risk. Even people who tan easily without burning add to their risk when they spend time in the sun unprotected. Other risk factors are outside anyone's control. Fair skin that burns easily, light-colored eyes, red or blond hair and many freckles increase risk. So does having many moles, several large ones, or atypical moles: the National Cancer Institute estimates that people with more than five atypical moles have about 10 times the melanoma risk of people with none. A personal history of melanoma, two or more close relatives with melanoma, and a weakened immune system, for example after an organ transplant, also raise risk. A few inherited conditions, such as familial atypical multiple mole melanoma syndrome, raise it sharply, but they are rare. Melanoma is much less common in people with darker skin, but it does occur, and it tends to be found at a later stage. In darker skin it typically appears on the palms, the soles of the feet or under a nail, often first as a dark streak running the length of the nail. Risk factors describe likelihood across groups of people: many people with several of them never develop melanoma, and some people with none do.

How It's Diagnosed

Evaluation starts with a look at the skin. A clinician, often a dermatologist (a doctor who specializes in skin), examines the spot in question and usually the rest of the skin, since a mole that looks unlike a person's other moles deserves a closer look. Many dermatologists use a dermatoscope, a handheld magnifying lens with a light that shows pigment patterns just beneath the surface. Photographs may be taken so later changes are easier to judge. A common checklist is ABCDE: asymmetry (one half does not match the other), an irregular, notched or blurred border, uneven color with shades of black, brown or tan and sometimes red, white, gray or blue, a diameter usually larger than 6 millimeters (about a quarter inch), and evolving, meaning change over weeks or months. A melanoma may show only one or two of these features, and change is often the most telling one. Appearance alone cannot confirm melanoma. The only way to diagnose it is a biopsy: the clinician removes all or part of the spot, usually in a few minutes in the office, and a pathologist examines the tissue under a microscope. Because early melanoma and an unusual mole can be hard to tell apart, a second pathologist's opinion is sometimes sought. If the biopsy shows melanoma, the report describes how thick it is in millimeters, measured from the skin surface to its deepest point, and whether the surface has broken down (ulceration). Together with whether cancer has reached the lymph nodes or beyond, these set the stage, from stage 0 (melanoma in situ, confined to the top layer of skin) to stage IV (spread to distant organs). As a reference point, a melanoma no more than 1 millimeter thick that has not reached the lymph nodes is stage I. When a melanoma has a higher chance of spreading, a sentinel lymph node biopsy may be offered: a tracer injected near the tumor shows which lymph node it drains to first, and that node is removed and checked for cancer. Scans and gene testing of the tumor, such as for a BRAF mutation, are used mainly when melanoma is more advanced.

Treatment Options

Ordinary and atypical moles do not need treatment, and removing them to prevent cancer is not normally recommended: very few turn into melanoma, and most melanomas start elsewhere. Clinicians remove moles that have changed or look suspicious, and people with many atypical moles are usually followed with regular skin checks rather than having moles cut out. Surgery is the main treatment for melanoma at every stage. A wide local excision removes the melanoma along with a margin of normal-looking skin around it. For melanoma in situ and most thin melanomas, this surgery is usually the whole treatment. A larger wound sometimes needs a skin graft to close it. If a sentinel lymph node contains only a small amount of cancer, regular ultrasound checks of the remaining nodes may be offered instead of removing them. When melanoma is thicker with a higher risk of returning, or has reached the lymph nodes, medicine may be added after surgery (adjuvant therapy) to lower the chance of it coming back, and is sometimes given before surgery as well. Two kinds of medicine are used. Immunotherapy, such as pembrolizumab (Keytruda) or nivolumab (Opdivo), is given by infusion and releases a brake on the immune system so it can attack melanoma cells. Its main trade-off is that the immune system can also inflame healthy organs, such as the bowel, lungs, liver or hormone glands. These reactions can be serious, which is why regular blood tests and check-ins continue throughout treatment. Targeted therapy, such as the pill combination dabrafenib (Tafinlar) with trametinib (Mekinist), works only when the melanoma carries a particular change in the BRAF gene, which is why the tumor is tested first. For melanoma that cannot be removed or has spread to distant organs, these immunotherapies and targeted drugs, alone or in combination, are the main treatments. Responses vary from person to person, and the choice depends on the tumor's genetic features, overall health and how side effects are tolerated. Other options include virus-based treatments injected directly into tumors, radiation, and surgery or chemotherapy to relieve symptoms. Clinical trials are worth asking about at any advanced stage.

What to Expect

For most people, moles simply come and go: some new ones appear through early adulthood and many fade later in life. Living with many or atypical moles mainly means protecting the skin from the sun, avoiding tanning beds, checking your own skin about once a month and having regular clinician exams. A yearly exam is common for people with more than five atypical moles, and every 3 to 6 months may be suggested when there is also a family history of melanoma. Photographs make it easier for both you and your clinician to notice change. The outlook for melanoma depends heavily on how early it is found. In the United States, about three in four melanomas are diagnosed before they have spread beyond the skin, and at that stage five-year relative survival (survival compared with people of the same age without melanoma) is close to 100 percent. Once melanoma has reached nearby lymph nodes the figure is about 76 percent, and after spread to distant organs it is about 34 percent. These are averages across many people and cannot predict any one person's course. Recovery from removal of a thin melanoma is usually a matter of wound care and a scar. Follow-up continues afterward because melanoma can return and because anyone who has had one is more likely to develop another. A typical plan after an early melanoma includes skin and lymph node exams every 6 to 12 months for several years; after a thicker or more advanced melanoma, every 3 to 6 months, sometimes with ultrasound or computed tomography (CT) scans. Monthly self-checks of the skin and of the lymph node areas in the neck, armpits and groin are part of the routine. Some side effects of immunotherapy can appear or persist after treatment ends, so new symptoms are worth mentioning at these visits.

When to Seek Help

Arrange a skin check when you notice a new mole or spot that looks different from your others, or when an existing mole changes in color, size, shape, texture or height, or starts to itch, become scaly, bleed or ooze. A new mole appearing after about age 40, when new moles become less common, deserves the same attention, as does a dark streak along a fingernail or toenail or a new dark spot on a palm or sole. Most of these changes turn out not to be melanoma, but a biopsy is the only way to be sure, and catching melanoma early changes the outlook. If you have been treated for melanoma, contact your care team promptly about a new lump, a change in or near the scar, or new symptoms that persist, such as pain, cough, shortness of breath, headaches or swelling in the abdomen. During immunotherapy, report any new symptom right away, because immune side effects can affect almost any organ and the plan depends on recognizing and managing them early.

Questions to Ask Your Doctor

  1. 1.Do any of my moles look unusual to you, and should any be biopsied or photographed for comparison?
  2. 2.Given my skin type, number of moles and family history, how often should my skin be checked, and by whom?
  3. 3.What does my pathology report say about the melanoma's thickness, ulceration and stage, and do I need a sentinel lymph node biopsy?
  4. 4.Would adding immunotherapy or targeted therapy lower my chance of the melanoma returning enough to be worth its side effects?
  5. 5.Should my close relatives have their skin checked because of my diagnosis?

Last reviewed • Oct 2026

Educational content, not medical advice.